Table 1

Patient characteristics

Patient NoAge/sexDiagnosisDuration of IBD (y)Previous surgeryPrednisolone dose (mg)/duration (days)CDAIEIMLocalisationCDAI after 3 applicationsDuration of remission/clinical course/follow up (months)
CD, Crohn’s disease; IC, indeterminate colitis; J, jejunum; I, ileum; C, colon; R, rectum; EIM, extraintestinal manifestation; PG, pyoderma gangrenosum; EN, erythema nodosum; PSC, primary sclerosing cholangitis.
*Second course of cyclophosphamide application after flare up (see patients and methods).
—, Data not available.
123/FCD10None60 iv/12294PGI, C, R11129/relapse, then second course
222/FCD1None80 po/21EN, arthritisI, C10235/remission/37
329/MIC16Explorative laparotomy and doubleloop ileostomy50 po/21292PSCI, C, R 5420/proctocolectomy due to an adenoma/38
420/FCD3None100 iv/18290PSCStomach, C 7218/relapse (steroid treatment)/39
519/MCD2Explorative laparotomy60/50303NoneJ, I, C 9625/25
630/FCD19Subtotal colectomy 1984, ileorectostomy 1987, 2 anastomosis resections 1988, 199760 po/19479ArthritisI, C189Clinical improvement but not remission
729/FCD9Sigmoid colon resection 1997, fistulae and abscess drainage 1997, 1999, 200080 iv/7264EN, arthritisI, C, R 06/relapse after a 5 month remission period (hemicolectomy)/12
1*25/FCD12None100 iv/21316NoneC, R6912/remission/12